Metraipolis › archive › dc_6fefd640b2ce
Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development — Europe PMC PMID:41894068
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41894068
- DOI
- 10.1007/s10555-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T19:57:58.046Z
- SHA-256 of the archived text
2565862e00ec8cd495308bef483960e83dfb41b96b5cc18f7c651826e84417cf- Stable URL of this page
https://metraipolis.com/documento/dc_6fefd640b2ce
How to cite
Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development — Europe PMC PMID:41894068 — Europe PMC (en), https://europepmc.org/article/MED/41894068 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fefd640b2ce (Metraipolis archive dc_6fefd640b2ce, sha256 2565862e00ec8cd495308bef483960e83dfb41b96b5cc18f7c651826e84417cf)
BibTeX
@misc{dc6fefd640b2ce,
title = {Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development — Europe PMC PMID:41894068},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41894068},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fefd640b2ce; sha256 2565862e00ec8cd495308bef483960e83dfb41b96b5cc18f7c651826e84417cf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41894068. Agents can read the archived copy with the MCP tool read_document.